Trikafta 100-50-75 MG/150 MG UU 84S
Ended Awarded Last action
- Contract number
- SPE2DR26FQJV6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,332
Award facts
- Contract value 100% obligated
- $19,332.22 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order valued at $19,332.22 to DMS Pharmaceutical Group Inc. for Trikafta 100-50-75 mg/150 mg tablets (84-count units) on December 31, 2025, with an ultimate completion date of January 2, 2026. The award utilizes firm fixed-price pricing with no set-aside designation, and performance will be executed in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler that has maintained a strong presence in federal pharmaceutical contracting since 2001, specializing in distributing branded and generic prescription medications, biologics, vaccines, and medical consumables to Department of Defense facilities.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, which carries a $499.999 billion ceiling and extends through December 31, 2036. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to ensure consistent pharmaceutical supply to military healthcare facilities worldwide. The contractor's extensive product portfolio and demonstrated performance across numerous prior delivery orders position it as a critical supplier within the Department of Defense's global medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FQJV6?
SPE2DR26FQJV6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26FQJV6 worth?
The government has obligated $19,332 on SPE2DR26FQJV6.
Is contract SPE2DR26FQJV6 an order under another contract?
Yes. SPE2DR26FQJV6 is a delivery order under SPE2DR25D9135, an indefinite delivery contract.
Was contract SPE2DR26FQJV6 competed?
The extent of competition for SPE2DR26FQJV6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award